- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 379.36M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.72B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.97B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $8.91B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $8.4B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $32.42B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $32.04B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $41.35B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $40.45B |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 405.76M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $28.22M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $746.24M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $1.09 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $1.10 |
| Net Income | Q1 2025 · Mar 31, 2024 | $442.47M |
| Revenue | Q1 2025 · Mar 31, 2024 | $3.26B |